Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Consumer News Weight Loss Drugs May Come With Serious Digestive Risks

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Weight Loss Drugs May Come With Serious Digestive Risks is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Weight Loss Drugs May Come With Serious Digestive Risks | RobinsPost News & Noticias

Weight loss medications can cause serious side effects: Experts explain the risks


In recent years, the use of weight-loss medications has surged. Attracted by quick results, many people start taking these drugs without proper medical guidance. Social media has also fueled this ... Read More

The Possible Risks and Side Effects of Stacker Brand Diet Pills


Each year, millions of people turn to diet pills to lose weight. As of 2022, about 15 percent of U.S. adults reported using a weight-loss supplement at some point in their lives. One popular ... Read More

Costco is offering discounts on weight loss drugs, but doctors are warning people about risks


CINCINNATI — Weight loss drugs like Ozempic and Wegovy just became significantly more affordable, with savings of nearly $1,000 per month available at Costco. But doctors say there's an important ... Read More

Are Compounded GLP-1 Weight Loss Drugs Really Banned?


Note: Compounded drugs are not approved by theU.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. Despite new rules limiting their manufacture, compounded ... Read More

GI Safety Similar for Popular Weight-Loss Drugs


Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes (T2D), an active-comparator cohort study showed. “We were somewhat surprised ... Read More

A New Study Found That Weight-Loss Drugs Like Ozempic Could Lower Your Heart Attack Risk


A new University College London study featuring 17,604 participants age 45 and up discovered that semaglutide -- a GLP-1 agonist found in weight-loss drugs like Ozempic and Wegovy -- decreases the ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus